Blog

4 April 2026

EVO301’s Novel IL-18 Targeting Shows Promise for Tough Atopic Dermatitis Cases

EVO301 targets IL-18 with a novel approach, offering hope for tough atopic dermatitis cases unresponsive to current treatments. Learn more...
Read more
EVO301’s Novel IL-18 Targeting Shows Promise for Tough Atopic Dermatitis Cases
Breakout Bulletin: Key Dermatology Advances and AAD 2026 Highlights

Breakout Bulletin: Key Dermatology Advances and AAD 2026 Highlights

Stay updated with key dermatology advances from AAD 2026, including breakthrough treatments for dermatomyositis and essential skin care insights.
5 04 2026
Read more
How Integrating Mental Health and Skin Care Is Transforming Treatment

How Integrating Mental Health and Skin Care Is Transforming Treatment

Discover how integrating mental health and skin care is revolutionizing treatment for chronic skin conditions, improving patient outcomes worldwide.
6 04 2026
Read more
Understanding the Bone–Vascular Link in Psoriasis: Impact on Heart and Bone Health

Understanding the Bone–Vascular Link in Psoriasis: Impact on Heart and Bone Health

Explore how psoriasis affects bone and heart health through the bone–vascular link, revealing risks and benefits of targeted therapies on...
7 04 2026
Read more
Envudeucitinib Shows Promising Results as Oral TYK2 Inhibitor for Psoriasis

Envudeucitinib Shows Promising Results as Oral TYK2 Inhibitor for Psoriasis

Envudeucitinib, a next-gen oral TYK2 inhibitor, shows promising phase 3 results for treating moderate to severe plaque psoriasis. Learn more...
2 04 2026
Read more
Effective Early Treatments for Managing Hidradenitis Suppurativa Pain and Scarring

Effective Early Treatments for Managing Hidradenitis Suppurativa Pain and Scarring

Discover effective early treatments for managing hidradenitis suppurativa pain and scarring to improve quality of life and skin health.
31 03 2026
Read more
Cross-Cultural Stigma and Challenges Faced by People with Vitiligo

Cross-Cultural Stigma and Challenges Faced by People with Vitiligo

Explore cross-cultural stigma and challenges faced by people with vitiligo, highlighting beliefs, discrimination, and coping across diverse communities.
28 03 2026
Read more
Sonelokimab Shows Promising Long-Term Results for Hidradenitis Suppurativa

Sonelokimab Shows Promising Long-Term Results for Hidradenitis Suppurativa

Sonelokimab shows promising long-term results in treating moderate to severe hidradenitis suppurativa, offering hope for better inflammation control.
29 03 2026
Read more
Biogen’s Litifilimab Shows Promise in Phase 2 Trial for Cutaneous Lupus

Biogen’s Litifilimab Shows Promise in Phase 2 Trial for Cutaneous Lupus

Biogen’s litifilimab shows promising Phase 2 results for cutaneous lupus, offering hope for a targeted treatment in this challenging skin...
30 03 2026
Read more